Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas E. Simms"'
Autor:
P. L. Summers, Frank J. Malinoski, Robert McNair Scott, Charles H. Hoke, Jeanne Burrous, Doria R. Dubois, William H. Bancroft, Kenneth H. Eckels, Sherman E. Hasty, Thomas E. Simms
Publikováno v:
The American journal of tropical medicine and hygiene. 43(2)
To determine safety and immunogenicity, a single 0.5 ml dose of a monovalent live-attenuated dengue (DEN) 4 (341750 Carib) vaccine was given sc to 3 groups of flavivirus nonimmune volunteers in increasing concentrations. Two recipients received 10(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6692d59d4fa0cbafa883425482297a43
https://pubmed.ncbi.nlm.nih.gov/2389825
https://pubmed.ncbi.nlm.nih.gov/2389825
Autor:
Thomas E. Simms
Publikováno v:
OAH Magazine of History. 2:12-15
[Editor's Note: According to the story of the "The White Buffalo Calf Pipe" as recounted in Teton Sioux Music, the sacred pipe was presented to the Sioux by the White Buffalo Maiden, a super natural being who turned into a white buffalo calf after gi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d083d4aeb575ccd811a285862e2b65f
https://doi.org/10.1093/maghis/2.3.12
https://doi.org/10.1093/maghis/2.3.12
Autor:
Peter L. Summers, Robert Scott, K. D. T. Jesrani, Thomas E. Simms, William H. Bancroft, Philip K. Russell, Doria R. Dubois, Kenneth H. Eckels, Charles H. Hoke, D. Tsoulos
Publikováno v:
Journal of Infectious Diseases. 149:1005-1010
A live dengue virus type 2 (dengue-2) vaccine (PR-159/S-1) was tested for reactogenicity and immunogenicity in a placebo-controlled, double-blind clinical trial involving 98 soldiers. Seroconversion rates based on the development of neutralizing anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41cf53d741e333a57b831d72d5eaf158
https://doi.org/10.1093/infdis/149.6.1005
https://doi.org/10.1093/infdis/149.6.1005
Publikováno v:
The Journal of infectious diseases. 143(6)
Because many patients with acute hepatitis B lack detectable hepatitis B surface antigen (HBsAg), a radioimmunoassay for IgM antibody to hepatitis B core antigen (anti-HBc) was developed and evaluated as a diagnostic test. IgM anti-HBc was detected i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2beda2f7e4ef0c12e0c1690df07f13
https://pubmed.ncbi.nlm.nih.gov/6788859
https://pubmed.ncbi.nlm.nih.gov/6788859